Cargando…

Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first

BACKGROUND: Due to improvements in early detection, treatment, and supportive care, the number of colorectal cancer (CRC) survivors is increasing; therefore, careful attention should always be paid to the second primary cancer (SPC) in treating these CRC patients. The present study attempts to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Li-Chu, Tai, Yi-Yun, Liao, Su-Mien, Lin, Tang-Yu, Shih, Ying-Ling, Chang, Se-Fen, Huang, Ching-Wen, Chan, Hon-Man, Huang, Che-Jen, Wang, Jaw-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997212/ https://www.ncbi.nlm.nih.gov/pubmed/24678904 http://dx.doi.org/10.1186/1477-7819-12-73

Ejemplares similares

Second Primary Cancers Following Colorectal Cancer
por: Huh, Jung Wook
Publicado: (2014)

Second primary colorectal cancer after the initial primary colorectal cancer
por: Yang, Lin, et al.
Publicado: (2018)

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
por: Birgisson, Helgi, et al.
Publicado: (2011)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2012)

Second Primary Cancers following Colorectal Cancer in Sicily, Italy
por: Collatuzzo, Giulia, et al.
Publicado: (2022)

Clinical Characteristics of Colorectal Cancer Patients With a Second Primary Cancer
por: Lee, Jin Woo, et al.
Publicado: (2014)

Machine Learning in Prediction of Second Primary Cancer and Recurrence in Colorectal Cancer
por: Ting, Wen-Chien, et al.
Publicado: (2020)

Risk of second primary colorectal cancer among colorectal cancer cases: A population-based analysis
por: Raj, Kavitha P., et al.
Publicado: (2011)

Ramucirumab in the second-line treatment of metastatic colorectal cancer: a narrative review of literature from clinical trials
por: Chen, Chou-Pin, et al.
Publicado: (2020)

Excessive risk of second primary cancers in young‐onset colorectal cancer survivors
por: He, Xingkang, et al.
Publicado: (2018)

Colorectal cancer risk in association with colorectal cancer as a second malignancy in relatives: a nationwide cohort study
por: Zheng, Guoqiao, et al.
Publicado: (2022)

Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
por: Chung, Joo Won, et al.
Publicado: (2017)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

The risk of developing second primary malignancies among colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness
por: Tsai, Hsiang-Lin, et al.
Publicado: (2019)

Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
por: Chen, Quan, et al.
Publicado: (2018)

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
por: Lee, Yu-Ting, et al.
Publicado: (2015)

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

The UK colorectal cancer screening pilot: results of the second round of screening in England
por: Weller, D, et al.
Publicado: (2007)

Second Primary Malignancies in Patients with Colorectal Cancer: A Population‐Based Analysis
por: Jia, Huixun, et al.
Publicado: (2020)

Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients
por: Halámková, Jana, et al.
Publicado: (2022)

Surgical resection for second primary colorectal cancer: a population-based study
por: Li, Ting, et al.
Publicado: (2023)

Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal Cancer
por: Otsu, Satoshi, et al.
Publicado: (2023)

Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes
por: Lun, Weijian, et al.
Publicado: (2023)

Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer
por: Huang, Chun-Ming, et al.
Publicado: (2020)

A Second Family with Probable CRAC (Colorectal Adenomata and Carcinoma) Syndrome—A New Familial Cancer
por: Morrison, P. J., et al.
Publicado: (1999)

Optimal Sequence and Second-Line Systemic Treatment of Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis
por: Wu, Chih-Chien, et al.
Publicado: (2021)

Treatment of Colorectal Cancer and Other GI Cancers in the COVID-19 Pandemic
por: Chu, Edward
Publicado: (2020)

XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer
por: CUI, CHENGXU, et al.
Publicado: (2014)

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review
por: Arnold, D, et al.
Publicado: (2018)

The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
por: Halámková, Jana, et al.
Publicado: (2023)

EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
por: Huang, Ching-Wen, et al.
Publicado: (2017)

Familial Associations of Colorectal Cancer with Other Cancers
por: Yu, Hongyao, et al.
Publicado: (2017)

Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer
por: Zheng, Guoqiao, et al.
Publicado: (2021)

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
por: Zheng, Guoqiao, et al.
Publicado: (2021)

GLUT1 gene is a potential hypoxic marker in colorectal cancer patients
por: Chung, Fu-Yen, et al.
Publicado: (2009)

Clinical Implication of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Combined with FOLFIRI in the First-line Setting()()
por: Lu, Chien-Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5goucisernhoehagpssmou220u